Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 1
1971 1
1972 2
1974 1
1975 2
1976 2
1977 1
1978 2
1979 2
1980 2
1981 2
1982 2
1983 1
1984 8
1986 4
1987 8
1988 7
1989 4
1990 4
1991 7
1992 8
1993 6
1994 6
1995 15
1996 8
1997 6
1998 6
1999 13
2000 7
2001 6
2002 20
2003 28
2004 16
2005 23
2006 21
2007 19
2008 24
2009 17
2010 36
2011 32
2012 40
2013 68
2014 49
2015 47
2016 43
2017 31
2018 57
2019 59
2020 46
2021 47
2022 54
2023 65
2024 70
2025 97
2026 33

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,070 results

Results by year

Filters applied: . Clear all
Page 1
Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.
Zhou C, Li X, Wang C, Zhang J. Zhou C, et al. Clin Rev Allergy Immunol. 2021 Dec;61(3):403-423. doi: 10.1007/s12016-021-08883-0. Epub 2021 Aug 17. Clin Rev Allergy Immunol. 2021. PMID: 34403083 Review.
Alopecia areata (AA) is a common chronic tissue-specific autoimmune disease, resulting in hair loss, that affects up to 2% of the general population. ...Multiple genetic and environment factors contribute to the pathogenesis of AA. There are several cl
Alopecia areata (AA) is a common chronic tissue-specific autoimmune disease, resulting in hair loss, that affects up to
Psychological Stress-Induced Pathogenesis of Alopecia Areata: Autoimmune and Apoptotic Pathways.
Ahn D, Kim H, Lee B, Hahm DH. Ahn D, et al. Int J Mol Sci. 2023 Jul 20;24(14):11711. doi: 10.3390/ijms241411711. Int J Mol Sci. 2023. PMID: 37511468 Free PMC article. Review.
Alopecia areata (AA) is an autoimmune dermatological disease with multifactorial etiology and is characterized by reversible hair loss in patches. ...Most studies demonstrated that the collapse of "immune privilege" plays a crucial role in the developm
Alopecia areata (AA) is an autoimmune dermatological disease with multifactorial etiology and is characterized b
How Our Microbiome Influences the Pathogenesis of Alopecia Areata.
Sánchez-Pellicer P, Navarro-Moratalla L, Núñez-Delegido E, Agüera-Santos J, Navarro-López V. Sánchez-Pellicer P, et al. Genes (Basel). 2022 Oct 14;13(10):1860. doi: 10.3390/genes13101860. Genes (Basel). 2022. PMID: 36292745 Free PMC article. Review.
Alopecia areata is a multifactorial autoimmune-based disease with a complex pathogenesis. As in all autoimmune diseases, genetic predisposition is key. The collapse of the immune privilege of the hair follicle leading to scalp loss is a major pa
Alopecia areata is a multifactorial autoimmune-based disease with a complex pathogenesis. As in all autoimmun
Alopecia Areata: Current Treatments and New Directions.
Dahabreh D, Jung S, Renert-Yuval Y, Bar J, Del Duca E, Guttman-Yassky E. Dahabreh D, et al. Am J Clin Dermatol. 2023 Nov;24(6):895-912. doi: 10.1007/s40257-023-00808-1. Epub 2023 Aug 22. Am J Clin Dermatol. 2023. PMID: 37606849 Review.
Alopecia areata is an autoimmune hair loss disease that is non-scarring and is characterized by chronic inflammation at the hair follicle level. ...T-helper (Th) 1/interferon skewing has traditionally been described as the driver of disease; however, recent i
Alopecia areata is an autoimmune hair loss disease that is non-scarring and is characterized by chronic inflammation at
Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences.
Yamaguchi HL, Yamaguchi Y, Peeva E. Yamaguchi HL, et al. Int J Mol Sci. 2024 Apr 17;25(8):4409. doi: 10.3390/ijms25084409. Int J Mol Sci. 2024. PMID: 38673994 Free PMC article. Review.
Both alopecia areata (AA) and vitiligo are distinct, heterogenous, and complex disease entities, characterized by nonscarring scalp terminal hair loss and skin pigment loss, respectively. ...Here, we summarize the commonalities and differences between AA and vitilig …
Both alopecia areata (AA) and vitiligo are distinct, heterogenous, and complex disease entities, characterized by nonscarring …
Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis.
Strazzulla LC, Wang EHC, Avila L, Lo Sicco K, Brinster N, Christiano AM, Shapiro J. Strazzulla LC, et al. J Am Acad Dermatol. 2018 Jan;78(1):1-12. doi: 10.1016/j.jaad.2017.04.1141. J Am Acad Dermatol. 2018. PMID: 29241771 Review.
Alopecia areata (AA) is a common, inflammatory, nonscarring type of hair loss. Significant variations in the clinical presentation of AA have been observed, ranging from small, well-circumscribed patches of hair loss to a complete absence of body and scalp hair. ...
Alopecia areata (AA) is a common, inflammatory, nonscarring type of hair loss. Significant variations in the clinical presenta
Two Phase 3 Trials of Baricitinib for Alopecia Areata.
King B, Ohyama M, Kwon O, Zlotogorski A, Ko J, Mesinkovska NA, Hordinsky M, Dutronc Y, Wu WS, McCollam J, Chiasserini C, Yu G, Stanley S, Holzwarth K, DeLozier AM, Sinclair R; BRAVE-AA Investigators. King B, et al. N Engl J Med. 2022 May 5;386(18):1687-1699. doi: 10.1056/NEJMoa2110343. Epub 2022 Mar 26. N Engl J Med. 2022. PMID: 35334197 Clinical Trial.
BACKGROUND: Alopecia areata is an autoimmune condition characterized by rapid hair loss in the scalp, eyebrows, and eyelashes, for which treatments are limited. Baricitinib, an oral, selective, reversible inhibitor of Janus kinases 1 and 2, may interrupt cyto …
BACKGROUND: Alopecia areata is an autoimmune condition characterized by rapid hair loss in the scalp, eyebrows, and eye …
Alopecia areata.
Ungar B, Renert-Yuval Y, Dlova NC, Jabbari A, King B, Mesinkovska NA, Rudnicka L, Sinclair R, Guttman-Yassky E. Ungar B, et al. Nat Rev Dis Primers. 2025 Nov 6;11(1):77. doi: 10.1038/s41572-025-00664-9. Nat Rev Dis Primers. 2025. PMID: 41198704 Review.
Alopecia areata is a common cause of non-scaring autoimmune hair loss, associated with substantial psychosocial burden. Alopecia areata is an autoimmune disease in which loss of immune privilege in hair follicles leads to local hair folli
Alopecia areata is a common cause of non-scaring autoimmune hair loss, associated with substantial psychosocial burden.
Alopecia areata: review of epidemiology, pathophysiology, current treatments and nanoparticulate delivery system.
Singh R, Kumar P, Kumar D, Aggarwal N, Chopra H, Kumar V. Singh R, et al. Ther Deliv. 2024 Mar;15(3):193-210. doi: 10.4155/tde-2023-0071. Epub 2024 Mar 7. Ther Deliv. 2024. PMID: 38449420 Review.
Alopecia areata (AA) is a kind of alopecia that affects hair follicles and nails. It typically comes with round patches and is a type of nonscarring hair loss. ...This review paper highlights the epidemiology, clinical features, pathogenesis and new tr
Alopecia areata (AA) is a kind of alopecia that affects hair follicles and nails. It typically comes with round patches
Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options.
Sterkens A, Lambert J, Bervoets A. Sterkens A, et al. Clin Exp Med. 2021 May;21(2):215-230. doi: 10.1007/s10238-020-00673-w. Epub 2021 Jan 1. Clin Exp Med. 2021. PMID: 33386567 Review.
Patients suffering from alopecia areata (AA) can lose hair in focal regions, the complete scalp, including eyelashes and eyebrows, or even the entire body. ...The prognosis is uncertain and is negatively influenced by the subtypes alopecia totalis and alop
Patients suffering from alopecia areata (AA) can lose hair in focal regions, the complete scalp, including eyelashes and eyebr …
1,070 results